Literature DB >> 11723133

The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region: studies using chimeric human and fly receptors.

Shinya Nishi1, Koji Nakabayashi, Brian Kobilka, Aaron J W Hsueh.   

Abstract

Lutropin (LH) and follitropin (FSH) receptors belong to a group of leucine-rich repeat-containing, G protein-coupled receptors (LGRs) found in vertebrates and flies. We fused the ectodomain of human LH or FSH receptors to the transmembrane region of fly LGR2. The chimeric human/fly receptors, unlike their wild type counterparts, exhibited ligand-independent constitutive activity. Because ectodomains likely interact with exoloops to constrain the receptors, individual exoloops of the chimeric receptor containing the ectodomain of the LH receptor and transmembrane region of fly LGR2 was replaced with LH receptor sequences. Chimeric receptors with the ectodomain and exoloop 2, but not exoloop 1 or 3, from LH receptors showed decreases in constitutive activity, but ligand treatment stimulated cAMP production. Furthermore, substitution of key resides in the hinge region of fly LGR2 with LH receptor sequences led to constitutive receptor activation; however, concomitant substitution of the homologous exoloop 2 of the LH receptor decreased G(s) coupling. These results suggest that the hinge region of the LH receptor interacts with exoloop 2 to constrain the receptor in an inactive conformation whereas ligand binding relieves this constraint, leading to G(s) activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723133     DOI: 10.1074/jbc.M109617200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Trans-activation, cis-activation and signal selection of gonadotropin receptors.

Authors:  MyoungKun Jeoung; ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

2.  The antibodies against the computationally designed mimic of the glycoprotein hormone receptor transmembrane domain provide insights into receptor activation and suppress the constitutively activated receptor mutants.

Authors:  Ritankar Majumdar; Reema Railkar; Rajan R Dighe
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

3.  Expression pattern of the orphan receptor LGR4/GPR48 gene in the mouse.

Authors:  Grégory Van Schoore; Fernando Mendive; Roland Pochet; Gilbert Vassart
Journal:  Histochem Cell Biol       Date:  2005-07-19       Impact factor: 4.304

4.  Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor.

Authors:  Gunnar Kleinau; Holger Jaeschke; Sandra Mueller; Bruce M Raaka; Susanne Neumann; Ralf Paschke; Gerd Krause
Journal:  FASEB J       Date:  2008-04-01       Impact factor: 5.191

5.  The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.

Authors:  Sandra Mueller; Gunnar Kleinau; Mariusz W Szkudlinski; Holger Jaeschke; Gerd Krause; Ralf Paschke
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

6.  Melanocortin-4 Receptor in Spotted Sea Bass, Lateolabrax maculatus: Cloning, Tissue Distribution, Physiology, and Pharmacology.

Authors:  Kai-Qiang Zhang; Zhi-Shuai Hou; Hai-Shen Wen; Yun Li; Xin Qi; Wen-Juan Li; Ya-Xiong Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-18       Impact factor: 5.555

7.  Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants.

Authors:  David Speck; Gunnar Kleinau; Mark Meininghaus; Antje Erbe; Alexandra Einfeldt; Michal Szczepek; Patrick Scheerer; Vera Pütter
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

Review 8.  Role of the Extracellular and Intracellular Loops of Follicle-Stimulating Hormone Receptor in Its Function.

Authors:  Antara A Banerjee; Smita D Mahale
Journal:  Front Endocrinol (Lausanne)       Date:  2015-07-17       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.